Venture Certified
| 기술평가보증기업(기금) | 2020-09-07 ~ 2022-09-06 | 20200111734 | 2020-09-07 |
| 혁신성장유형 | 2022-09-07 ~ 2025-09-06 | 20221110030159 | 2020-09-07 |
| 혁신성장유형 | 2025-09-07 ~ 2028-09-06 | 20251112030025 | 2020-09-07 |
Revenue CAGR +3.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 21B | 18B | 19B |
| Operating Profit | 1.6B | 1.3B | 1.0B |
| Net Profit | 1.4B | 1.2B | 1.0B |
| Total Assets | 8.5B | 8.2B | 6.9B |
| Total Liabilities | 4.3B | 5.2B | 5.1B |
| Total Equity | 4.2B | 3.0B | 1.8B |
▲ 12.2%
▲ 37.0%
▲ 21.3%
▼ 56.5%
▼ 32.6%
| Name | Position | Role |
|---|---|---|
| 이상준 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 동구",
"ceo_name": "이상준",
"certificate": [
{
"cert_number": "20200111734",
"changes": "",
"disclosure_date": "2020-09-07",
"first_cert_date": "2020-09-07",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-09-07 ~ 2022-09-06"
},
{
"cert_number": "20221110030159",
"changes": "",
"disclosure_date": "2022-11-10",
"first_cert_date": "2020-09-07",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2022-09-07 ~ 2025-09-06"
},
{
"cert_number": "20251112030025",
"changes": "",
"disclosure_date": "2025-11-12",
"first_cert_date": "2020-09-07",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2025-09-07 ~ 2028-09-06"
}
],
"company_name": "㈜준바이오",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 150000000,
"cost_of_sales": 1323867000,
"current_assets": 363908000,
"current_liabilities": 58280000,
"gross_profit": 606173000,
"net_income": 101061000,
"net_income_bs": 98501000,
"non_current_assets": 321240000,
"non_current_liabilities": 450000000,
"non_operating_expenses": 13587000,
"non_operating_income": 14882000,
"operating_profit": 99766000,
"revenue": 1930040000,
"sga_expenses": 506407000,
"total_assets": 685148000,
"total_equity": 176868000,
"total_liabilities": 508280000
},
"2023": {
"capital_stock": 150000000,
"cost_of_sales": 1104034000,
"current_assets": 530087000,
"current_liabilities": 120893000,
"gross_profit": 669765000,
"net_income": 118428000,
"net_income_bs": 118428000,
"non_current_assets": 286402000,
"non_current_liabilities": 400300000,
"non_operating_expenses": 18523000,
"non_operating_income": 9232000,
"operating_profit": 127719000,
"revenue": 1773799000,
"sga_expenses": 542046000,
"total_assets": 816489000,
"total_equity": 295296000,
"total_liabilities": 521193000
},
"2024": {
"capital_stock": 150000000,
"cost_of_sales": 1411454000,
"current_assets": 621297000,
"current_liabilities": 135965000,
"gross_profit": 666392000,
"net_income": 139120000,
"net_income_bs": 129369000,
"non_current_assets": 231494000,
"non_current_liabilities": 292161000,
"non_operating_expenses": 17286000,
"non_operating_income": 584000,
"operating_profit": 155822000,
"revenue": 2077846000,
"sga_expenses": 510570000,
"total_assets": 852791000,
"total_equity": 424665000,
"total_liabilities": 428126000
}
},
"industry": "기타 곡물 가공품 제조업",
"investment": [],
"main_products": "칼슘강화찹쌀외다수",
"phone": "070-4388-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |